⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3858578 | 0.77 | ALDH1A1 (0.30) | — | |
| SCHEMBL11340026 | 0.74 | — | — | |
| SCHEMBL29622 | 0.71 | — | — | |
| SCHEMBL7155990 | 0.71 | — | — | |
| SCHEMBL8063782 | 0.71 | — | — | |
| SCHEMBL27856342 | 0.71 | — | — | |
| SCHEMBL13176961 | 0.69 | — | — | |
| SCHEMBL7016552 | 0.69 | TSHR (0.33) | — | |
| SCHEMBL3985694 | 0.69 | — | — | |
| Urea SCHEMBL9791646 | 0.69 | ALDH1A1 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023122745-A1 | COMPOSITIONS AND METHODS FOR PURIFYING POLYRIBONUCLEOTIDES | FLAGSHIP PIONEERING INNOVATIONS VI, LLC (US) | 2023-06-29 | — | — | WO | disclosed |
| EP-1960777-B1 | SERUM-FREE EXPANSION OF CELLS IN CULTURE | CHOONGWAE PHARMA CORP (KR) | 2009-10-21 | — | — | EP | disclosed |
| WO-2007062243-A9 | SERUM-FREE EXPANSION OF CELLS IN CULTURE | CHOONGWAE PHARMA CORP (KR) | 2008-12-04 | — | — | WO | disclosed |
| EP-1960777-A2 | SERUM-FREE EXPANSION OF CELLS IN CULTURE | Choongwae Pharma Corporation (KR) | 2008-08-27 | — | — | EP | disclosed |
| US-20070128669-A1 | Serum-free expansion of cells in culture | INSTITUTE FOR CHEMICAL GENOMICS (US) | 2007-06-07 | — | — | US | disclosed |
| WO-2007062243-A2 | SERUM-FREE EXPANSION OF CELLS IN CULTURE | CHOONGWAE PHARMA CORPORATION (KR) | 2007-05-31 | — | — | WO | disclosed |
| US-6686394-B1 | POTENT ANTINEOPLASTIC ACTIVITY WITHOUT SYSTEMIC TOXICITY OR MUTAGENICITY | SOVAR, SOCIETE EN COMMANDITE (CA) | 2004-02-03 | — | — | US | disclosed |